FI860417A0 - Bakteriecellytprotein med foermaoga att binda fibronektin, fibrinogen, kollagen och laminin, foerfarande foer framstaellning av proteinet och anvaendning av detsamma vid profylaktisk vaord. - Google Patents

Bakteriecellytprotein med foermaoga att binda fibronektin, fibrinogen, kollagen och laminin, foerfarande foer framstaellning av proteinet och anvaendning av detsamma vid profylaktisk vaord.

Info

Publication number
FI860417A0
FI860417A0 FI860417A FI860417A FI860417A0 FI 860417 A0 FI860417 A0 FI 860417A0 FI 860417 A FI860417 A FI 860417A FI 860417 A FI860417 A FI 860417A FI 860417 A0 FI860417 A0 FI 860417A0
Authority
FI
Finland
Prior art keywords
och
fibrinogen
laminin
vaord
proteinet
Prior art date
Application number
FI860417A
Other languages
English (en)
Other versions
FI84431B (fi
FI84431C (fi
FI860417A (fi
Inventor
Magnus Hoeoek
Martin Kjell Lindberg
Torkel Mikael Wadstroem
Original Assignee
Alfa Laval Agri Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Laval Agri Int filed Critical Alfa Laval Agri Int
Publication of FI860417A publication Critical patent/FI860417A/fi
Publication of FI860417A0 publication Critical patent/FI860417A0/fi
Publication of FI84431B publication Critical patent/FI84431B/fi
Application granted granted Critical
Publication of FI84431C publication Critical patent/FI84431C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Materials For Medical Uses (AREA)
FI860417A 1984-05-30 1986-01-29 Foerfarande foer framstaellning av ett fibronektinbindande cellyteprotein. FI84431C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8402938A SE454403B (sv) 1984-05-30 1984-05-30 Anvendning av ett cellyteprotein med fibronektin-, fibrinogen-, kollagen-, och/eller lamininbindande egenskaper vid framstellning av sarbehandlingsmedel
SE8402938 1984-05-30
PCT/SE1985/000227 WO1985005553A1 (en) 1984-05-30 1985-05-30 Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and profylactic treatment
SE8500227 1985-05-30

Publications (4)

Publication Number Publication Date
FI860417A FI860417A (fi) 1986-01-29
FI860417A0 true FI860417A0 (fi) 1986-01-29
FI84431B FI84431B (fi) 1991-08-30
FI84431C FI84431C (fi) 1991-12-10

Family

ID=20356083

Family Applications (1)

Application Number Title Priority Date Filing Date
FI860417A FI84431C (fi) 1984-05-30 1986-01-29 Foerfarande foer framstaellning av ett fibronektinbindande cellyteprotein.

Country Status (13)

Country Link
EP (1) EP0163623B1 (fi)
JP (1) JPH0747541B2 (fi)
AT (1) ATE52543T1 (fi)
AU (1) AU600886B2 (fi)
CA (1) CA1340401C (fi)
DE (1) DE3577579D1 (fi)
ES (1) ES8900019A1 (fi)
FI (1) FI84431C (fi)
IE (1) IE59203B1 (fi)
NO (1) NO164992C (fi)
NZ (1) NZ212244A (fi)
SE (1) SE454403B (fi)
WO (1) WO1985005553A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8702272L (sv) * 1987-06-01 1988-12-02 Alfa Laval Agri Int Fibronektinbindande protein samt dess framstaellning
SE8801723D0 (sv) * 1988-05-06 1988-05-06 Staffan Normark Fibronectin binding protein as well as its preparation
SE8801894D0 (sv) * 1988-05-20 1988-05-20 Alfa Laval Agri Int Fibronektinbindande protein
SE8901687D0 (sv) * 1989-05-11 1989-05-11 Alfa Laval Agri Int Fibronectin binding protein as well as its preparation
US5440014A (en) * 1990-08-10 1995-08-08 H+E,Uml/Oo/ K; Magnus Fibronectin binding peptide
SE9003374D0 (sv) * 1990-10-22 1990-10-22 Alfa Laval Agri Int A collagen binding protein as well as its preparation
US5980908A (en) * 1991-12-05 1999-11-09 Alfa Laval Ab Bacterial cell surface protein with fibronectin, fibrinogen, collagen and laminin binding ability, process for the manufacture of the protein and prophylactic treatment
AU4837193A (en) * 1992-09-21 1994-04-12 Alfa-Laval Agri International Aktiebolag Fibrinogen binding protein
JPH0840932A (ja) * 1994-07-29 1996-02-13 Kitasato Inst:The スタフイロコッカス属菌感染症の予防ワクチン及び治療用抗体並びにそれの製造法
GB9415902D0 (en) * 1994-08-05 1994-09-28 Smithkline Beecham Plc Method of treatment
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6908994B1 (en) 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
CA2517439C (en) 2003-03-07 2013-07-23 Wyeth Holdings Corporation Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
BRPI0614734A2 (pt) 2005-08-10 2011-04-12 Arne Forsgren Ab interação de moraxella catarrhalis com células epiteliais, proteìnas da matriz extracelular e com o sistema de complemento
BRPI1015567A2 (pt) 2009-06-22 2021-08-31 Wyeth Llc Composições imunogênicas de antígenos de staphylococcus aureus
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
TW201302779A (zh) 2011-04-13 2013-01-16 Glaxosmithkline Biolog Sa 融合蛋白質及組合疫苗

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide

Also Published As

Publication number Publication date
EP0163623B1 (en) 1990-05-09
JPS61502334A (ja) 1986-10-16
SE454403B (sv) 1988-05-02
SE8402938L (sv) 1985-12-01
EP0163623A2 (en) 1985-12-04
SE8402938D0 (sv) 1984-05-30
CA1340401C (en) 1999-02-23
ATE52543T1 (de) 1990-05-15
FI84431B (fi) 1991-08-30
NO860321L (no) 1986-01-29
DE3577579D1 (de) 1990-06-13
EP0163623A3 (en) 1987-02-25
IE851337L (en) 1985-11-30
IE59203B1 (en) 1994-01-26
AU600886B2 (en) 1990-08-30
ES8900019A1 (es) 1988-11-01
FI84431C (fi) 1991-12-10
NO164992B (no) 1990-08-27
WO1985005553A1 (en) 1985-12-19
FI860417A (fi) 1986-01-29
JPH0747541B2 (ja) 1995-05-24
ES543635A0 (es) 1988-11-01
NO164992C (no) 1990-12-05
NZ212244A (en) 1989-03-29

Similar Documents

Publication Publication Date Title
FI860417A0 (fi) Bakteriecellytprotein med foermaoga att binda fibronektin, fibrinogen, kollagen och laminin, foerfarande foer framstaellning av proteinet och anvaendning av detsamma vid profylaktisk vaord.
DE68925002D1 (de) Verfahren zur Herstellung von optisch-aktiven alpha-substituierten organischen Säuren und Mikroorganismen und Enzyme, die dafür verwendet werden.
ES2056963T3 (es) Agentes antibacterianos.
DE3580054D1 (de) Chitinase produzierende bakterien.
ATE130031T1 (de) Verwendungen viraler enzyme.
ATE41034T1 (de) Herstellung von protein a.
DE68913817D1 (de) Verfahren zur Herstellung einer dem Kefir ähnlichen Sauermilch.
DE3789428D1 (de) Mikroorganismen, fähig zur Laktoseassimilation.
ES8800160A1 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
BR8702649A (pt) Composicao biocida,processo para inibicao do crescimento de microorganismos,meio,couro ou madeira,composto e complexo ferrico
EP0230053A3 (en) 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
DE3876769D1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden.
DE58907274D1 (de) VERFAHREN ZUR STEIGERUNG VON ENZYM-AKTIVITÄTEN UND DER SYNTHESELEISTUNG VON MIKROORGANISMEN UND HöHEREN PFLANZEN.
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
ATE95188T1 (de) Zellulaere amphipatische proteine in aggregierten formen und verfahren zur herstellung und reinigung diese proteine.
DE3884922D1 (de) Verfahren zur Herstellung von thermostabilen alpha-Amylasen durch Kultivierung von überproduzierenden Mikroorganismen.
IT8620042A0 (it) Metodo per conservare pellami, pelli e pellicce grezzi.
DE69637278D1 (de) Methode zur herstellung von thrombin
DE3885380D1 (de) Verfahren zur Herstellung von modifiziertem, ferromagnetischem Chromdioxid.
ATE23189T1 (de) Verfahren zur herstellung von sphaerischen zellaggregaten von mikroorganismen.
RO86571B1 (ro) Mediu de cultura pentru izolarea bacilului koch
TH1345A (fi)
ATE17372T1 (de) Verfahren zur herstellung genetisch modifizierter mikroorganismen.
DE3483871D1 (de) Verfahren und zubereitung zur steigerung des wachstums von mikroorganismen.
TH1345EX (th) ปฏิชีวนะ (กรรมวิธี)

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ALFA-LAVAL AGRI INTERNATIONAL AB

MA Patent expired